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ABSTRACT 
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk 
assessments carried out by the competent authority of the rapporteur Member State, the United Kingdom, for the 
pesticide active substance spiromesifen are reported.  The context of the peer review was that required by 
Commission Regulation (EU) No 188/2011.  The conclusions were reached on the basis of the evaluation of the 
representative uses of spiromesifen as an insecticide and acaricide on cucumber, courgette, pepper, tomato, 
eggplant (aubergine), French bean, melon, strawberry and ornamentals in permanent greenhouses.  The reliable 
endpoints concluded as being appropriate for use in regulatory risk assessment, derived from the available 
studies and literature in the dossier peer reviewed, are presented.  Missing information identified as being 
required by the regulatory framework is listed.  Concerns are identified.   
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SUMMARY 
Spiromesifen is a new active substance for which, in accordance with Article 6(2) of Council Directive 
91/414/EEC, the United Kingdom (hereinafter referred to as the ‘RMS’) received an application from 
Bayer CropScience AG for approval.  Complying with Article 6(3) of Directive 91/414/EEC, the 
completeness of the dossier was checked by the RMS.  The European Commission recognised in 
principle the completeness of the dossier by Commission Decision 2003/105/EC. 
The RMS provided its initial evaluation of the dossier on spiromesifen in the Draft Assessment Report 
(DAR), which was received by the EFSA on 9 March 2004.  The peer review was initiated on 16 April 
2004 by dispatching the DAR for consultation of the Member States and the applicant Bayer 
CropScience AG.  Susequently the comments received on the DAR were evaluated by the RMS and 
the need for additional data was agreed in an evaluation meeting in November 2005.  Remaining 
issues, as well as further data made available by the applicant upon request, were evaluated in a series 
of scientific meetings with Member State experts in September 2006.  A final discussion of the 
outcome of the expert consultation took place with representatives from the Member States in April 
2006, leading to the conclusion laid down in EFSA Scientific Report (2007) 105, which was finalised 
on 13 June 2007. 
Following the submission of additional information from the applicant, the RMS provided an updated 
evaluation of the dossier on spiromesifen in the form of Addenda to the DAR, which were received by 
the EFSA on 28 September 2009.  The European Commission requested EFSA to organise a peer 
review of the updated evaluation and revise its conclusion on spiromesifen.  The peer review was 
initiated on 5 October 2011 by dispatching the Addenda to the DAR for consultation of the Member 
States and the applicant Bayer CropScience AG. 
Following consideration of the comments received on the Addenda to the DAR, it was concluded that 
EFSA should conduct an expert consultation in the area of ecotoxicology, and should adopt a 
conclusion on whether spiromesifen can be expected to meet the conditions provided for in Article 5 
of Directive 91/414/EEC, in accordance with Article 8 of Commission Regulation (EU) No 188/2011. 
The conclusions laid down in this report were reached on the basis of the evaluation of the 
representative uses of spiromesifen as an insecticide and acaricide on cucumber, courgette, pepper, 
tomato, eggplant (aubergine), French bean, melon, strawberry and ornamentals in permanent 
greenhouses, as proposed by the applicant. Full details of the representative uses can be found in 
Appendix A to this report. 
In the area of identity, physical/chemical/technical properties and methods of analysis no data gaps or 
areas of concern are identified. 
In the area of mammalian toxicology no data gaps or areas of concern were identified. 
In the area of residues no areas of concern were identified. A data gap was identified for additional 
rotational crop data in soil-based greenhouse systems.  
The assessment of fate and behaviour in the environment was conducted based on the representative 
uses in a permanent greenhouse, and where the substrate is not used or spread on open fields at least 
until residues of parent and metabolites in soil and/or substrate are below the LOQ.  The HPLC 
estimated Koc was accepted solely for the assessment of greenhouse uses.  Potential groundwater 
contamination by spiromesifen and soil metabolites M01 and M09 was assessed with a modified 
scenario to represent greenhouse conditions.  The risk assessment of groundwater contamination 
above the regulatory limit of 0.1 µg/L by spiromesifen and its soil metabolites M01 and M09 cannot 
be finalised due to the lack of PECGW calculations updated with the Q10 of 2.58, and a data gap was 
identified.   Peer review of the pesticide risk assessment of the active substance spiromesifen
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The ecotoxicological risk assessment was conducted for the representative uses in a permanent 
greenhouse, where exposure of wildlife is considered to be negligible.  A data gap was identified to 
further address the risk to aquatic invertebrates.  
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BACKGROUND 
In accordance with Article 80(1)(a) of Regulation (EC) No 1107/2009,
3 Council Directive 
91/414/EEC
4 continues to apply with respect to the procedure and conditions for approval for active 
substances for which a decision recognising in principle the completeness of the dossier was adopted 
in accordance with Article 6(3) of that Directive before 14 June 2011. 
Commission Regulation (EU) No 188/2011
5 (hereinafter referred to as ‘the Regulation’) lays down the 
detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for 
the assessment of active substances which were not on the market on 26 July 1993.  This regulates for 
the European Food Safety Authority (EFSA) the procedure for organising the consultation of Member 
States and the applicant for comments on the initial evaluation in the Draft Assessment Report (DAR) 
provided by the rapporteur Member State (RMS), and the organisation of an expert consultation, 
where appropriate.   
In accordance with Article 8 of the Regulation, EFSA is required to adopt a conclusion on whether the 
active substance is expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC 
within 4 months from the end of the period provided for the submission of written comments, subject 
to an extension of 2 months where an expert consultation is necessary, and a further extension of upto 
8 months where additional information is required to be submitted by the applicant in accordance with 
Article 8(3).  
In accordance with Article 6(2) of Council Directive 91/414/EEC, the United Kingdom (hereinafter 
referred to as the ‘RMS’) received an application from Bayer CropScience AG for approval.   
Complying with Article 6(3) of Directive 91/414/EEC, the completeness of the dossier was checked 
by the RMS.  The European Commission recognised in principle the completeness of the dossier by 
Commission Decision 2003/105/EC
6. 
The RMS provided its initial evaluation of the dossier on spiromesifen in the DAR (United Kingdom, 
2004), which was received by the EFSA on 9 March 2004.  The peer review was initiated on 16 April 
2004 by dispatching the DAR for consultation of the Member States and the applicant Bayer 
CropScience AG.  Susequently the comments received on the DAR were evaluated by the RMS and 
the need for additional data was agreed in an evaluation meeting in November 2005.  Remaining 
issues, as well as further data made available by the applicant upon request, were evaluated in a series 
of scientific meetings with Member State experts in September 2006.  A final discussion of the 
outcome of the expert consultation took place with representatives from the Member States in April 
2006, leading to the conclusion laid down in EFSA Scientific Report (2007) 105 (EFSA, 2007a), 
which was finalised on 13 June 2007. 
Following the submission of additional information from the applicant, the RMS provided an updated 
evaluation of the dossier on spiromesifen in the form of Addenda to the DAR (United Kingdom, 
2012), which were received by the EFSA on 28 September 2009.  The European Commission 
requested EFSA to organise a peer review of the updated evaluation and revise its conclusion on 
spiromesifen.   
                                                      
3 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ No L 309, 
24.11.2009, p. 1-50. 
4 Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 
19.8.1991, p. 1-32, as last amended.  
5 Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the implementation of 
Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the market 
2 years after the date of notification of that Directive. OJ No L 53, 26.2.2011, p. 51-55. 
6 Commission Decision of 17 February 2003 recognising in principle the completeness of the dossiers submitted for detailed 
examination in view of the possible inclusion of spiromesifen and metrafenone in Annex I to Council Directive 91/414/EEC.  
OJ L 43, 18.2.2003, p. 45-46. Peer review of the pesticide risk assessment of the active substance spiromesifen
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The peer review of the updated evaluation was initiated on 5 October 2011 by dispatching the 
Addenda to the DAR for consultation of the Member States and the applicant Bayer CropScience AG.  
The comments received were collated by the EFSA and forwarded to the RMS for compilation and 
evaluation in the format of a Reporting Table.  The applicant was invited to respond to the comments 
in column 3 of the Reporting Table. The comments and the applicant’s response were evaluated by the 
RMS in column 3. 
The need for expert consultation and the necessity for additional information to be submitted by the 
applicant in accordance with Article 8(3) of the Regulation were considered in a telephone conference 
between the EFSA, the RMS, and the European Commission on 26 January 2012. On the basis of the 
comments received, the applicant’s response to the comments and the RMS’s evaluation thereof it was 
concluded that additional information should be requested from applicant, and that the EFSA should 
organise an expert consultation in the area of ecotoxicology. 
The outcome of the telephone conference, together with EFSA’s further consideration of the 
comments is reflected in the conclusions set out in column 4 of the Reporting Table. All points that 
were identified as unresolved at the end of the comment evaluation phase and which required further 
consideration, including those issues to be considered in an expert consultation, and the additional 
information to be submitted by the applicant, were compiled by the EFSA in the format of an 
Evaluation Table. 
The conclusions arising from the consideration by the EFSA, and as appropriate by the RMS, of the 
points identified in the Evaluation Table, together with the outcome of the expert consultation where 
this took place, were reported in the final column of the Evaluation Table. 
A final consultation on the conclusions arising from the peer review of the risk assessment took place 
with Member States via a written procedure in July / August 2012.   
This conclusion report summarises the outcome of the peer review of the risk assessment on the active 
substance and the representative formulation evaluated on the basis of the representative uses as an 
insecticide and acaricide on cucumber, courgette, pepper, tomato, eggplant (aubergine), French bean, 
melon, strawberry and ornamentals in permanent greenhouses, as proposed by the applicant. A list of 
the relevant end points for the active substance as well as the formulation is provided in Appendix A. 
In addition, a key supporting document to this conclusion is the Peer Review Report, which is a 
compilation of the documentation developed to evaluate and address all issues raised in the peer 
review, from the initial commenting phase to the conclusion. The Peer Review Report (EFSA, 2012) 
comprises the following documents, in which all views expressed during the course of the peer review, 
including minority views, can be found: 
•  the comments received on the Addenda to the DAR, 
•  the Reporting Table (26 January 2012),  
•  the Evaluation Table (29 August 2012), 
•  the report of the scientific consultation with Member State experts (where relevant), 
•  the comments received on the assessment of the additional information (where relevant), 
•  the comments received on the draft EFSA conclusion. 
Given the importance of the DAR including its addendum (compiled version of July 2012 containing 
all individually submitted addenda (United Kingdom, 2012)) and the Peer Review Report, both 
documents are considered respectively as background documents A and B to this conclusion.  The 
background documents of the Peer Review Report (EFSA, 2007b) and the Final Addendum (United Peer review of the pesticide risk assessment of the active substance spiromesifen
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Kingdom, 2007) developed and prepared during the course of the initial peer review process are made 
publicly available as part of the background documentation to the original conclusion, finalised on 13 
June 2007 (EFSA, 2007a). 
 Peer review of the pesticide risk assessment of the active substance spiromesifen
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THE ACTIVE SUBSTANCE AND THE FORMULATED PRODUCT 
Spiromesifen is the ISO common name for 3-mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-
dimethylbutyrate (IUPAC).  
The representative formulated product for the evaluation was ‘Oberon SC 240 (BSN 2060 SC 240)’, a 
suspension concentrate (SC) containing 240 g/l spiromesifen. 
The evaluated representative uses are as an insecticide and acaricide as proposed by the applicant, 
comprising overall spraying to cucumber, courgette, pepper, tomato, eggplant (aubergine), French 
bean, melon, strawberry and ornamentals in permanent greenhouses only. Full details of the 
representative uses evaluated can be found in Appendix A. 
CONCLUSIONS OF THE EVALUATION 
1.  Identity, physical/chemical/technical properties and methods of analysis 
The following guidance documents were followed in the production of this conclusion: 
SANCO/3030/99 rev.4 (European Commission, 2000), Sanco/10597/2003 – rev. 8.1 (European 
Commission, 2009), and SANCO/825/00 rev. 8.1 (European Commission, 2010). 
The minimum purity of spiromesifen as manufactured should not be less than 965 g/kg. The technical 
material contains N,N-dimethylacetamide, which has to be regarded as a relevant impurity the 
maximum content is 4 g/kg.  
The main data regarding the identity of spiromesifen and its physical and chemical properties are 
given in Appendix A. 
Residues of spiromesifen and spiromesifen-enol (M01) in food of plant origin, soil, and water are 
analysed by HPLC-MS/MS, however the residue definition for monitoring in ground water is still 
open. As a consequence pending on the final residue definition, a method to determine all components 
of the residue definition might be required. A method for products of animal origin is not required as 
no MRLs are proposed. An HPLC-MS/MS method for residues of spiromesifen in air is available. A 
method for body fluids and tissues is not required as the active substance is not classified as toxic or 
very toxic. 
2.  Mammalian toxicity 
The following guidance documents were followed in the production of this conclusion: 
SANCO/221/2000 rev. 10 - final (European Commission, 2003), SANCO/222/2000 rev. 7 (European 
Commission, 2004b) and SANCO/10597/2003 – rev. 8.1 (European Commission, 2009). 
The data gap identified in the original EFSA Conclusion (EFSA, 2007a) for a case and/or data to show 
that the full scale production is not significantly more toxic than the reference source, in particular 
with regard to reproductive toxicity, due to the toxicological properties of N,N-dimethylacetamide 
(Repro 2/R61; Xn; R20/21) was addressed, showing that no concern is expected for exposure to the 
impurity in the full scale production when specified at a maximum content of 4 g/kg. 
Spiromesifen has a low acute oral, dermal and inhalational toxicity in rats. It is not a skin or eye 
irritant. It is a skin sensitiser (the risk phrase R43 “May cause sensitisation by skin contact” was 
considered*
7). Histological findings in adrenals with decreased plasma cholesterol levels were seen in 
short-term and long-term studies in rodents, together with induction of microsomal hepatic enzymes, 
also present in dogs. Spiromesifen did not show any genotoxic or carcinogenic potential. The relevant 
                                                      
7 It should be noted that classification is formally proposed and decided in accordance with Regulation (EC) No 1272/2008.  
Proposals for classification made in the context of the evaluation procedure under Regulation (EC) No 1107/2009 are not 
formal proposals. Peer review of the pesticide risk assessment of the active substance spiromesifen
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repeat dose No Observed Adverse Effect Level (NOAEL) is 3 mg/kg bw per day. Spiromesifen was 
tested in reproductive and developmental toxicity studies, showing effects only as a consequence of 
maternal toxicity. The parental and offspring NOAEL is 3.3 mg/kg bw per day, while the reproductive 
NOAEL is 14.2 mg/kg bw per day. The maternal and developmental NOAEL is 10 mg/kg bw per day. 
Spiromesifen did not raise any concern for neurotoxic effects (a NOAEL of 200 mg/kg bw per day 
was established in an acute neurotoxicity study in rats).  
The Acceptable Daily Intake (ADI) is 0.03 mg/kg bw per day, based on the relevant long-term toxicity 
NOAEL of 3 mg/kg bw per day applying an uncertainty factor of 100; the Acute Reference Dose 
(ARfD) is 2 mg/kg bw based on the acute neurotoxicity NOAEL and an uncertainty factor of 100. The 
Acceptable Operator Exposure Level (AOEL) is 0.015 mg/kg bw per day based on the relevant 
NOAEL of 3 mg/kg bw per day, using an assessment factor of 100 and correcting for incomplete oral 
absorption (50%).  
Operator exposure levels are below the AOEL for operators wearing protective gloves when mixing 
and loading and a protective coverall and protective gloves during application. The estimated worker 
exposure is 48% and 54% of the AOEL for vegetables and ornamentals, respectively. Bystanders are 
unlikely to be exposed to spiromesifen from applications in permanent greenhouses. 
3.  Residues 
The assessment in the residue section below is based on the guidance documents listed in the 
document 1607/VI/97 rev.2 (European Commission, 1999). 
Spiromesifen was the main component of the residue in mature tomato fruits (86% of the TRR), in 
lettuce (58% TRR), and in cotton seed and gin trash (17% and 26 % TRR). Metabolites observed 
were, amongst others, spiromesifen-enol (M01) (<3% TRR in tomato and lettuce; up to 50% TRR in 
cotton commodities), spiromesifen-4-hydroxymethyl (M02), and its glucoside (M03) (sum approx. 7% 
TRR in tomato and cotton, 16% in lettuce).  A major metabolite in lettuce was also dihydroxy 
spiromesifen enol (M04) (6% TRR). All other components were present in insignificant amounts. 
Globally, the picture of metabolism was similar across the tested crops.  
A radiolabel hydrolysis study covering a range of conditions simulating food processing demonstrated 
that spiromesifen was hydrolytically unstable. Spiromesifen was primarily degraded to spiromesifen-
enol (M01) which was present at up to 89% of the terminal residues. Other degradation products were 
not significant. Processing studies determined levels of spiromesifen and spiromesifen-enol (M01) in 
processed tomato, bean and strawberry products. Spiromesifen-enol (M01) was observed at 
significantly higher levels after processing compared to the levels present in the raw commodities. 
Hence, processing factors were calculated on the basis of the sum of residues of spiromesifen and 
spiromesifen-enol (M01) expressed as spiromesifen. 
The residue definition for food of plant origin was proposed as spiromesifen and spiromesifen-enol 
(M01) expressed as spiromesifen for both risk assessment and monitoring purposes. 
A sufficient number of residues trials are available in climbing French beans, cucumbers, peppers, 
tomatoes (extrapolated to eggplant (aubergine)), strawberries and melons, grown in greenhouses 
across Europe. MRLs could be proposed for these crops. All trials analysed separately for 
spiromesifen and spiromesifen-enol (M01), and their sum was expressed as spiromesifen. The trial 
results are supported by validated analytical methods and acceptable freezer storage stability data. 
Although in some crops significant degradation of spiromesifen to spiromesifen-enol (M01) was found 
upon freezer storage over two years, the sum of residues of both compounds seemed to be sufficiently 
stable since residues did not degrade beyond metabolite M01during this period of freezer storage.   
To support uses in soil-based greenhouse systems, the fate of spiromesifen was studied in rotational 
crops. The metabolites identified were broadly similar to those in primary crops. Because of the 
predominance of metabolite M02 (including its conjugates) in rotational crops it has been proposed to Peer review of the pesticide risk assessment of the active substance spiromesifen
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define the sum of metabolites M02, M03 (M02 glucoside) and M02-conjugates as the relevant residue 
in rotational crops. Since the situation in rotational crops is unclear for some rotational practices, the 
above proposal is not considered to be finalised. In the available residue trials, rotating tomatoes with 
tomatoes, residues of M02 and its conjugates in tomato fruits were below the LOQ of 0.01 mg/kg. 
However, the data do not address rotation sequences other than fruiting vegetables rotated with 
fruiting vegetables, even if a potential for measurable residues in leafy crops was identified in the 
confined rotational study. Therefore further rotational residues trials in other crop groups were 
considered necessary.  Depending on the significance of the residue levels in the quantitative trials, it 
may also be necessary to give consideration to the nature of the unknowns observed in the confined 
study. In view of this data gap it cannot be concluded whether MRLs will need to be proposed for 
rotational crops other than fruiting vegetables in soil-based greenhouse systems. 
Livestock metabolism and feedings studies with spiromesifen were not required to support the 
representative uses. However, metabolism data with goat and hen were submitted but their quality did 
not meet current standards. Therefore a residue definition for animal products could not be proposed to 
facilitate future assessments.  
A consumer risk assessment was conducted using the EFSA PRIMo model and the MRL proposals for 
the primary crops. The TMDI was less than 14% of the ADI for all consumer groups included in the 
model. The IESTIs for peppers, strawberries, tomatoes, aubergines, cucumbers, courgettes, melons 
and French beans were all below 3% of the ARfD.  The risk assessment does not consider potential 
residues in certain crops that can be rotated in soil-based greenhouse systems, however this has no 
impact on the consumer risk assessment in view of the large margin of safety for the representative 
uses. 
4.  Environmental fate and behaviour 
The assessment of fate and behaviour in the environment was based on representative greenhouse 
uses, assuming a permanent greenhouse and that the substrate is not used or spread on open fields at 
least until residues of parent and metabolites in soil and/or substrate are below the LOQ.  
Spiromesifen is low to moderately persistent in soil under dark aerobic conditions at 20 ºC. It is 
hydrolysed to form the major soil metabolite M01 (max 85 % AR after 14 d), which oxidises to major 
metabolite M09 (max 14.1 % AR after 90 d). Both metabolites were shown to be of low to high 
persistence in soil.  
Photolysis does not seem to contribute to the environmental degradation of spiromesifen in soil but 
may accelerate the degradation of its metabolite M01.  
PEC soil were calculated based on worst case laboratory half-lives and maximum formation of 
metabolites M01 and M09.  
The HPLC method following OECD guideline 121 (OECD, 2001) was used to estimate the Koc value 
for spiromesifen. According to this test spiromesifen should be classified as immobile in soil. During 
the initial peer review of the 2004 dossier the use of this value was accepted for the assessment of 
greenhouse uses, however, it was noted that if outdoor uses are to be proposed then a standard 
adsorption/desorption study at neutral conditions should be provided.  Therefore, a data gap was 
identified. According to the equilibrium batch adsorption/desorption studies, metabolites M01 and 
M09 were very highly mobile in soil.  
Hydrolysis of spiromesifen is pH dependent, being faster at alkaline pH and produces the major 
metabolite M01 that does not hydrolyse further.  
The photolytic half-life of spiromesifen in water was 1.7 d in laboratory conditions. Three major 
aqueous photolysis metabolites were identified. The experts agreed that in the case of spiromesifen 
adsorption to sediment seems to be the dominant route of dissipation from the water phase. Therefore, Peer review of the pesticide risk assessment of the active substance spiromesifen
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no further data were required for these metabolites. M01 was found to be stable to photolysis in water. 
The experts agreed to propose that spiromesifen is classified as not readily biodegradable.  
In the two dark aerobic water/sediment experiments with alkaline water phase, spiromesifen degraded 
in the whole systems with half-lives of 4.1 d and 7.8 d. The only major metabolite identified in both 
water and sediment was M01 (max. water 84.1 % AR after 63 d; max. sed. 38 % after 90 d), which is 
relatively stable in the whole system. Mineralization was practically negligible and unextractable 
residue in the sediment amounted to 3 – 16 % AR after 120 d. PECSW were calculated using the Dutch 
assumption of 0.1 % loss of the active substance for the parent and metabolite M01. In the case of 
metabolite M01, it was assumed that no degradation occurred between applications. Worst case 
PECSED were calculated based on the same model assuming in this case no degradation between 
applications either for the parent or for the metabolite M01 (FOCUS, 2001; FOCUS, 2008). 
Potential groundwater contamination by spiromesifen and soil metabolites M01 and M09 was 
calculated by the applicant in its original submission with FOCUS-PELMO and a modified scenario to 
represent greenhouse conditions.  In this calculation neither parent nor metabolites exceeded the limit 
of 0.1 µg/L.  In the context of the peer rveiew of the updated evaluation, additional information was 
requested from the applicant for re-calculation of the PECGW with the updated Q10 of 2.58 (EFSA 
2007c).  No new calculation was provided by the applicant, therefore, a data gap has been identified 
for new PECGW calculations with a FOCUS GW scenario adapted to representative uses in protected 
crops in the EU (EFSA, 2010) with a Q10 of 2.58 (EFSA, 2004 and EFSA, 2007c, FOCUS, 2000 or 
FOCUS, 2009). 
5.  Ecotoxicology 
The risk assessment was based on the following documents: European Commission (2002a, 2002b, 
2002c), SETAC (2001). 
Spiromesifen was discussed at the PRAPeR experts’ meeting for ecotoxicology (PRAPeR 03) in 
September 2006 and at the Pesticides Peer Review meeting (PPR 91) in April 2012. 
The ecotoxicological risk assessment was conducted for the representative uses in a permanent 
greenhouse where exposure of wildlife is considered to be negligible. For non-permanent structures 
the risk assessment for non-target organisms should be further considered. 
Since direct exposure of birds and mammals via contaminated food items was considered negligible 
for the representative uses the risk was concluded as low. A risk assessment for fish-eating birds and 
mammals was performed, and the first tier TERs indicated a low risk from secondary poisoning.  
Spiromesifen is very toxic to fish and aquatic invertebrates. The risk to fish, algae and sediment-
dwelling insects was assessed as low based on the Dutch exposure model. However the long-term 
TER for daphnids was below the trigger of 10. The experts at the PRAPeR 03 concluded that risk 
refinement was required for aquatic invertebrates. A mesocosm study was subsequently submitted and 
evaluated in the Addendum 8 from September 2009 (United Kingdom, 2012). This study was also 
discussed at the PPR 91, and concerns were expressed that reported declines in dissolved oxygen 
levels in mesocosm water, which occurred shortly before treatment, may have reduced the sensitivity 
of the study to detect treatment related effects. The experts concluded that a NOEC could not be 
defined from this study due to several effects identified at the lowest concentration. Furthermore, the 
NOEAEC could not be defined because the recovery was not clearly demonstrated for some species at 
the lowest concentration. It was noted that only 2 applications were tested in the study. The experts 
concluded that the representative uses, with 4 applications, could lead to more adverse effects. 
Although the interval between the two applications tested was lower than the representative uses, it 
was not clear that these applications were toxicologically independent. Overall, it was concluded that 
for the representative uses, the risk assessment for aquatic invertebrates should be further addressed.  
A data gap was identified. Peer review of the pesticide risk assessment of the active substance spiromesifen
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The risk of the major metabolite in the water phase M01 and the soil metabolite M09 to aquatic 
organisms was assessed as low.  
Adverse effects on bumblebees were observed at an exposure of 0.72 mg a.s./bee/week. The risk to 
natural populations of honeybee and bumblebee species is considered to be low because of negligible 
exposure. If bumblebees are used as pollinators in the greenhouse the observed effects should be 
considered further. 
High mortality (>30%) of non-target arthropods was observed at application rates much lower than the 
representative use (i.e. 216 g spiromesifen/ha). Exposure of natural populations of non-target 
arthropods is considered to be low for the representative uses ,and hence the risk is considered to be 
low. If biological control is used in the greenhouse then the observed effects on Coccinella 
septempunctata and Typhlodromus pyri need to be considered further. The risk to non-target plants 
and biological methods of sewage treatment was assessed as low. 
No risk assessment was conducted for earthworms or other soil non-target macro- and micro-
organisms because exposure was considered to be negligible for the representative uses in greenhouses 
that are permanent structures.  
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6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental 
compartments 
6.1.  Soil 
Compound 
(name and/or code)  Persistence Ecotoxicology 
spiromesifen 
low to moderate 
 (DT50 lab = 2.6 d – 17.9 d) 
Low risk identified 
M01  
low to high  
(DT50 lab = 8.8 d – 101.6 d) 
Low risk identified 
M09 
low to high  
(DT50 lab = 1.7 d – 223.6 d) 
Low risk identified 
6.2.  Ground water 
Compound 
(name and/or code)  Mobility in soil 
>0.1  μg/L 1m depth for 
the representative uses
(at least one FOCUS 
scenario or relevant 
lysimeter) 
Pesticidal activity  Toxicological relevance  Ecotoxicological activity 
spiromesifen 
immobile 
(Koc = 30900 mL / g with 
HPLC method) 
Data gap  Yes  Yes 
High risk identified for 
aquatic organisms in 
surface water. 
M01  
very highly mobile  
Kfoc = 1.2 – 8.3 mL / g 
Data gap  No data available  No data available 
Low risk identified for 
aquatic organisms in 
surface water. Peer review of the pesticide risk assessment of the active substance spiromesifen
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M09 
very highly mobile  
Koc = 3 mL / g  
Data gap  No data available  No data available 
Low risk identified for 
aquatic organisms in 
surface water. 
6.3.  Surface water and sediment 
Compound 
(name and/or code)  Ecotoxicology 
spiromesifen High  risk  identified  for aquatic organisms in surface water. 
M01   Low risk identified for aquatic organisms in surface water. 
6.4.  Air 
Compound 
(name and/or code)  Toxicology 
spiromesifen  Not acutely toxic via inhalation 
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7.  List of studies to be generated, still ongoing or available but not peer reviewed 
This is a complete list of the data gaps identified during the peer review process, including those areas 
where a study may have been made available during the peer review process but not considered for 
procedural reasons (without prejudice to the provisions of Article 7 of Directive 91/414/EEC 
concerning information on potentially harmful effects). 
  For soil-based greenhouse systems, rotational crop data are required in crops other than fruiting 
vegetables that are realistically expected to occur in crop rotations (relevant for all representative 
uses; submission date proposed by the applicant: unknown; see section 3). 
  Batch equilibrium adsorption/desorption study in soil (relevant for field uses in case they are 
applied for at MS level; see section 4). 
  New PECGW calculations with a FOCUS GW scenario adapted to representative uses in protected 
crops in the EU using the Q10 of 2.58 (relevant for all representative uses evaluated; submission 
date proposed by the applicant: unknown; see section 4). 
  The risk to aquatic invertebrates to be further addressed (relevant for all representative uses; 
submission date proposed by the applicant: unknown; see section 5). 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified 
  Operators should wear protective gloves when mixing and loading and a protective coverall and 
protective gloves during application.  
  The environmental risk assessment has been performed assuming that spiromesifen is applied in a 
permanent greenhouse and that the substrate is not used or spread on open fields at least until 
residues of parent and metabolites in soil and/or substrate are below the LOQ. 
9.  Concerns 
9.1.  Issues that could not be finalised 
An issue is listed as an issue that could not be finalised where there is not enough information 
available to perform an assessment, even at the lowest tier level, for the representative uses in line 
with the Uniform Principles of Annex VI to Directive 91/414/EEC and where the issue is of such 
importance that it could, when finalised, become a concern (which would also be listed as a critical 
area of concern if it is of relevance to all representative uses). 
1.  The risk assessment for groundwater contamination above the regulatory limit of 0.1 µg/L by 
spiromesifen and its soil metabolites M01 and M09 cannot be finalised due to the lack of PECGW 
calculations updated with the Q10 of 2.58. 
9.2.  Critical areas of concern 
An issue is listed as a critical area of concern where there is enough information available to perform 
an assessment for the representative uses in line with the Uniform Principles of Annex VI to Directive 
91/414/EEC, and where this assessment does not permit to conclude that for at least one of the 
representative uses it may be expected that a plant protection product containing the active substance 
will not have any harmful effect on human or animal health or on groundwater or any unacceptable 
influence on the environment.   
An issue is also listed as a critical area of concern where the assessment at a higher tier level could not 
be finalised due to a lack of information, and where the assessment performed at the lower tier level 
does not permit to conclude that for at least one of the representative uses it may be expected that a Peer review of the pesticide risk assessment of the active substance spiromesifen
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plant protection product containing the active substance will not have any harmful effect on human or 
animal health or on groundwater or any unacceptable influence on the environment. 
2.  A high risk was identified for aquatic invertebrates. 
9.3.  Overview of the concerns identified for each representative use considered 
(If a particular condition proposed to be taken into account to manage an identified risk, as listed in 
section 8, has been evaluated as being effective, then ‘risk identified’ is not indicated in this table.) 
Representative use 
Cucumber, courgette, pepper, tomato, eggplant (aubergine), 
French bean, melon, strawberry and ornamentals in permanent 
greenhouses 
Operator risk 
Risk identified   
Assessment not 
finalised   
Worker risk 
Risk identified   
Assessment not 
finalised   
Bystander risk 
Risk identified   
Assessment not 
finalised   
Consumer risk 
Risk identified   
Assessment not 
finalised   
Risk to wild non 
target terrestrial 
vertebrates 
Risk identified   
Assessment not 
finalised   
Risk to wild non 
target terrestrial 
organisms other 
than vertebrates 
Risk identified   
Assessment not 
finalised   
Risk to aquatic 
organisms 
Risk identified  X
2 
Assessment not 
finalised   
Groundwater 
exposure active 
substance 
Legal parametric 
value breached   
Assessment not 
finalised  X
1 
Groundwater 
exposure 
metabolites 
Legal parametric 
value breached   
Parametric value 
of 10µg/L
(a) 
breached 
 
Assessment not 
finalised  X
1 
Comments/Remarks   
The superscript numbers in this table relate to the numbered points indicated in sections 9.1 and 9.2.  Where there is no 
superscript number see sections 2 to 6 for further information. 
(a):  Value for non-relevant metabolites prescribed in SANCO/221/2000-rev 10-final, European Commission, 2003 Peer review of the pesticide risk assessment of the active substance spiromesifen
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APPENDICES 
APPENDIX A – LIST OF END POINTS FOR THE ACTIVE SUBSTANCE AND THE REPRESENTATIVE 
FORMULATION 
Appendix A.1: Identity, Physical and Chemical Properties, Details of Uses, Further Information 
Active substance (ISO Common Name) ‡  Spiromesifen  
Function (e.g. fungicide)  Insecticide, acaricide 
 
Rapporteur Member State  United Kingdom 
Co-rapporteur Member State  -- 
 
Identity (Annex IIA, point 1) 
Chemical name (IUPAC) ‡  3-mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-
dimethylbutyrate 
Chemical name (CA) ‡  2-oxo-3-(2,4,6-trimethylphenyl)-1-oxaspiro[4.4]non-
3-en-4-yl 3,3-dimethylbutanoate 
CIPAC No ‡  747 
CAS No ‡  283594-90-1 
EEC No (EINECS or ELINCS) ‡  - 
FAO Specification ‡ (including year of 
publication) 
- 
Minimum purity of the active substance as 
manufactured ‡ (g/kg) 
965 g/kg full scale production 
Identity of relevant impurities (of toxicological, 
environmental and/or other significance) in the 
active substance as manufactured (g/kg) 
N,N-dimethylacetamide 
Maximum content 4 g/kg. 
Molecular formula ‡  C23H30O4 
Molecular mass ‡  370.49 g/mol 
Structural formula ‡ 
 
O
O
CH3
CH3 C H3
O
O
C H3
C H3
CH3
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Physical-chemical properties (Annex IIA, point 2) 
Melting point (state purity) ‡  96.7-98.7C 
Boiling point (state purity) ‡  Not determined due to decomposition 
Temperature of decomposition  Colour change during test (at unspecified 
temperature) ; the limiting temperature of this test 
was 375C; exothermic decomposition starts above 
300 °C. 
Appearance (state purity) ‡  Colourless crystals 
Relative density (state purity) ‡  1.13 at 20C 
Surface tension  Not determined due to low solubility 
Vapour pressure (in Pa, state temperature) ‡  At 20C at 20C 7 x 10
-6 Pa 
Henry’s law constant (Pa m
3 mol 
-1) ‡  2 x 10
-2 Pa m3 mol-1 at 20C 
Solubility in water ‡ (g/L or mg/L, state 
temperature) 
pH 4: 0.10 to 0.13 mg/L at 20C 
pH 7: 0.10 to 0.13 mg/L at 20C 
pH 9: 0.10 to 0.13 mg/L at 20C 
Solubility in organic solvents ‡ (in g/L or mg/L, 
state temperature) 
At 20C 
aliphatic hydrocarbon: heptane   23 g/L 
aromatic hydrocarbon: xylene   >250 g/L 
halogenated hydrocarbon:  
    1,2-dichloromethane   >250 g/L 
alcohol: 2-propanol   115 g/L 
             1-octanol   60 g/L 
ketone: acetone   >250 g/L 
ester: ethyl acetate   >250 g/L 
acetonitrile   >250 g/L 
polyethylene glycol   22 g/L 
dimethylsulfoxide   55 g/L 
Partition co-efficient (log POW) ‡ (state pH and 
temperature) 
log Pow measured as 4.552 
Hydrolytic stability (DT50) ‡ (state pH and 
temperature) 
At 50C 
pH 4           2.2 days 
pH 7           1.7 days 
pH 9           2.6 hours 
 
At 25C 
pH 4          53.3 days 
pH 7          24.8 days 
pH 9            4.3 days  Peer review of the pesticide risk assessment of the active substance spiromesifen
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Dissociation constant ‡  Dissociation is not expected to occur. 
UV/VIS absorption (max.) ‡ (if absorption > 
290 nm state  at wavelength) 
neutral medium 
(Lmol
-1cm
-1)@214nm=2.34 x10
4 
the UV spectra show no significant absorbance 
above 290 nm 
Flammability ‡  Not highly flammable 
Explosive properties ‡  Not explosive 
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List of representative uses evaluated* 
 
Crop and/ 
or situation 
 
 
 
(a) 
Member 
State 
or 
Country 
Product 
name 
F 
G 
or 
I 
 
(b) 
Pests or 
Group of 
pests 
Controlled 
 
(c) 
Formulation Application  Application rate per 
treatment 
PHI 
(days) 
 
 
 
(l) 
Remarks 
 
 
 
 
(m) 
Type 
 
 
(d-f) 
Conc. 
of as 
 
(i) 
method 
kind 
 
(f-h) 
growth stage 
& season 
 
(j) 
number
max 
 
(k) 
interval 
between 
applications
 
kg as/hL 
 
 
(n) 
water 
L/ha 
max 
kg as/ha
max 
Cucumber /  
Courgette 
EU 
North / 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies  
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1500 0.216 3   
Pepper EU 
North / 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies 
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1500 0.216 3   
Tomato / 
Eggplant 
EU 
North / 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies 
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12.  0.0144 1500 0.216 3   
French Beans  EU 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies  
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1000 0.144 3   
Melon EU 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies 
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1000 0.144 3   
Strawberry EU 
North / 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies 
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1000 0.144 3   Peer review of the pesticide risk assessment of the active substance spiromesifen
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Crop and/ 
or situation 
 
 
 
(a) 
Member 
State 
or 
Country 
Product 
name 
F 
G 
or 
I 
 
(b) 
Pests or 
Group of 
pests 
Controlled 
 
(c) 
Formulation Application  Application rate per 
treatment 
PHI 
(days) 
 
 
 
(l) 
Remarks 
 
 
 
 
(m) 
Type 
 
 
(d-f) 
Conc. 
of as 
 
(i) 
method 
kind 
 
(f-h) 
growth stage 
& season 
 
(j) 
number
max 
 
(k) 
interval 
between 
applications
 
kg as/hL 
 
 
(n) 
water 
L/ha 
max 
kg as/ha
max 
Ornamentals EU 
North / 
South 
Oberon SC 
240 (BSN 
2060 SC 240) 
 
G 
mites and 
white flies 
SC 240  g/L overall 
spray 
1
st-4
th app : 
start at begin 
of infestation
4  10 - 12  0.0144 1000 0.144 n.a.   
 
Remarks:  *  Uses for which risk assessment could not been concluded due to lack of essential     (h)  Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between 
    data are marked grey      the plants - type of equipment used must be indicated 
  (a)  For crops, the EU and Codex classifications (both) should be used; where relevant,     (i)  g/kg or g/L 
    the use situation should be described (e.g. fumigation of a structure)    (j)  Growth stage at last treatment (BBCH Monograph, Growth Stages of Plants, 
  (b)  Outdoor or field use (F), glasshouse application (G) or indoor application (I)      1997, Blackwell, ISBN 3-8263-3152-4), including where relevant, information on  
 (c)  e.g. biting and suckling insects, soil born insects, foliar fungi, weeds      season at time of application 
 (d)  e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR)    (k)  The minimum and maximum number of application possible under practical  
  (e)  GCPF Codes - GIFAP Technical Monograph No 2, 1989      conditions of use must be provided 
 (f)  Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench    (l)  PHI - minimum pre-harvest interval 
  (g)  All abbreviations used must be explained    (m)  Remarks may include: Extent of use/economic importance/restrictions 
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Appendix A.2: Methods of Analysis 
Analytical methods for the active substance (Annex IIA, point 4.1) 
Technical as (principle of method)  GC FID 
Impurities in technical as (principle of method)  HPLC UV 
Plant protection product (principle of method)  HPLC UV (DAD) 
 
Analytical methods for residues (Annex IIA, point 4.2) 
Residue definitions for monitoring purposes 
Food of plant origin  spiromesifen and spiromesifen-enol (M01) expressed 
as spiromesifen 
Food of animal origin  Not proposed 
Soil spiromesifen 
Water   surface   spiromesifen 
  drinking/ground   spiromesifen, M01 and M09 (open) 
Air spiromesifen 
 
Monitoring/Enforcement methods 
Food/feed of plant origin (principle of method 
and LOQ for methods for monitoring 
purposes) 
Spiromesifen: HPLC MS/MS LOQ 0.01 mg/kg 
(validated in orange, rape seed, tomato and wheat 
grain, plus ILV on tomato and wheat grain).   
Spiromesifen-enol: HPLC MS/MS LOQ 0.01 mg/kg 
(validated in orange, rape seed, tomato and wheat 
grain, plus ILV on tomato and wheat grain).   
Food/feed of animal origin (principle of 
method and LOQ for methods for monitoring 
purposes) 
Not required as no MRLs are proposed 
Soil (principle of method and LOQ)  Spiromesifen: HPLC MS/MS LOQ 0.01 mg/kg 
Spiromesifen-enol: HPLC MS/MS LOQ 0.01 mg/kg
Water (principle of method and LOQ)  Spiromesifen: HPLC MS/MS LOQ 0.05 µg/L 
Spiromesifen-enol: HPLC MS/MS LOQ 0.05 µg/L 
(validated in surface water) 
Air (principle of method and LOQ)  Spiromesifen HPLC-MS/MS LOQ 4 µg/m3  
Body fluids and tissues (principle of method 
and LOQ) 
Not required as the active substance is not classified 
as toxic or very toxic. 
 
Classification and proposed labelling (Annex IIA, point 10) 
with regard to physical/chemical data  No classification required 
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Appendix A.3: Impact on Human and Animal Health 
Absorption, distribution, excretion and metabolism in mammals (Annex IIA, point 5.1) 
Rate and extent of oral absorption‡  Rapid, but incomplete total rate of absorption 
amounted to at least 48% 
Distribution ‡  Widely 
Potential for accumulation ‡  Negligible 
Rate and extent of excretion ‡  Rapid, only negligible radioactivity was found in 
the tissues and organs 72 hours after the 
administration 
Metabolism in animals ‡  Complete 
Toxicologically relevant compounds ‡ 
(animals and plants) 
Spiromesifen 
Toxicologically relevant compounds‡ 
(environment) 
Spiromesifen 
 
 
Acute toxicity (Annex IIA, point 5.2) 
Rat LD50 oral ‡  >2000 mg/kg bw 
Rat LD50 dermal ‡  >2000 mg/kg bw 
Rat LC50 inhalation ‡  >4.87 mg/L (highest achievable concentration) 
Skin irritation ‡  None 
Eye irritation ‡  None 
Skin sensitization  (test method used and result)  Positive in a Magnusson & Kligman assay  R43
 
 
Short term toxicity (Annex IIA, point 5.3) 
Target / critical effect ‡  Adrenals and metabolic disturbance (reduced 
cholesterol) 
Relevant oral NOAEL‡  3 mg/kg bw per day (mouse) 
Relevant dermal NOAEL‡  1000 mg/kg bw per day (rat, not most sensitive 
species) 
Relevant inhalation NOAEL ‡  5.0 mg spiromesifen/m
3 per day for four weeks (rat)
 
 
Genotoxicity ‡ (Annex IIA, point 5.4) 
…………………………………………….. Negative  in vitro (Ames test, a mammalian cell 
gene mutation assay with V79 cells, and a 
cytogenetic test in V79 cells) and in vivo (mouse 
bone marrow micronucleus test) Peer review of the pesticide risk assessment of the active substance spiromesifen
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Long term toxicity and carcinogenicity (Annex IIA, point 5.5) 
Target/critical effect ‡  Adrenal glands 
Relevant NOAEL ‡  3 mg/kg bw per day 
Carcinogenicity ‡  Not carcinogenic 
 
 
Reproductive toxicity (Annex IIA, point 5.6) 
Reproduction target / critical effect  Reproduction: 
Reduced oestrous cycling frequency, increased 
number of ovarian primordial follicles (both 
considered related to strong general systemic 
toxicity) 
Parental: 
Decreased bodyweights in F1 males and F1 females
Offspring: 
Reduced bodyweights during lactation at 120 ppm 
Relevant reproductive NOAEL   14.2 mg/kg bw per day 
Relevant parental NOAEL   3.3 mg/kg bw per day 
Relevant neonatal NOAEL   30 ppm (3.3 mg/kg bw per day) 
Developmental target / critical effect  Developmental:  
Slightly more advanced ossification of phalangeal 
and single skull bones (toxicological relevance 
equivocal) 
Maternal:  
Decreased feed intake and amount of faeces, 
transient bodyweight loss, decreased bodyweight 
gain, decreased corrected bodyweight gains 
Relevant developmental NOAEL :  10 mg/kg bw per day 
Relevant maternal NOAEL :  10 mg/kg bw per day 
 
 
Neurotoxicity / Delayed neurotoxicity ‡ (Annex IIA, point 5.7) 
……………………………………………..  No clear evidence of neurotoxicity. 
 
 
Other toxicological studies ‡ (Annex IIA, point 5.8)  
…………………………………………….. None 
 
 
Medical data ‡ (Annex IIA, point 5.9) 
.....................................................................  No negative effects on the health of workers have Peer review of the pesticide risk assessment of the active substance spiromesifen
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been reported as a result of experimental biological 
testing or field testing of spiromesifen formulations.
 
Summary (Annex IIA, point 5.10)  Value Study Safety  factor 
ADI ‡  0.03 mg/kg bw 
per day 
90 day and 18 
month mouse 
studies  
100 
AOEL ‡  0.015 mg/kg bw 
per day 
90 day mouse 
study  
100 (correction 
of incomplete 
oral absorption 
a factor of 0.5)
ARfD ‡ (acute reference dose)  2 mg/kg bw  Acute 
neurotoxicity 
study 
100 
 
Dermal absorption (Annex IIIA, point 7.3) 
Oberon SC 240  3% for dermal absorption is assumed for both the 
concentrate and the in-use dilution 
 
Exposure scenarios (including method of calculation) 
Operator  Levels of systemic exposure to spiromesifen for 
operators applying ‘Oberon SC 240’ are estimated 
to be below the AOEL (24% hand lance application 
and 34% knapsack application) for operators 
wearing protective gloves when mixing and loading 
and a protective coverall and protective gloves 
during application.  
Workers  Levels of systemic exposure for spiromesifen for 
re-entry workers are 48% and 54% of the AOEL for 
vegetables and ornamentals, respectively.  
Bystanders  Bystanders are unlikely to be exposed to 
spiromesifen from applications in greenhouses.  
 
Classification and proposed labelling (Annex IIA, point 10) 
with regard to toxicological data  Irritant 
R43   May cause sensitisation by skin contact 
 
S24   Avoid contact with skin 
S37   Wear suitable gloves 
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Appendix A.4:  Residues 
Metabolism in plants (Annex IIA, point 6.1 and 6.7, Annex IIIA, point 8.1 and 8.6) 
Plant groups covered  Fruit (tomato); oilseed (cotton); leafy (lettuce) 
Rotational crops  Leafy (spinach); cereals (wheat); root (turnip) 
Plant residue definition for monitoring  Parent spiromesifen and spiromesifen-enol (M01) 
expressed as spiromesifen equivalents (factor of 1.36 
is applied to convert the enol to parent equivalents). 
Plant residue definition for risk assessment  Parent spiromesifen and spiromesifen-enol (M01) 
expressed as spiromesifen equivalents (factor of 1.36 
is applied to convert the enol to parent equivalents). 
Conversion factor (monitoring to risk 
assessment) 
None 
 
 
Metabolism in livestock (Annex IIA, point 6.2 and 6.7, Annex IIIA, point 8.1 and 8.6) 
Animals covered  Ruminant (Goat); poultry (hen) 
Animal residue definition for monitoring  No proposal (deficiencies in the studies are noted) 
Animal residue definition for risk assessment  No proposal (deficiencies in the studies are noted) 
Conversion factor (monitoring to risk 
assessment) 
not applicable 
Metabolism in rat and ruminant similar (yes/no) yes 
Fat soluble residue: (yes/no)  yes 
 
 
Residues in succeeding crops (Annex IIA, point 6.6, Annex IIIA, point 8.5) 
……………………………………………..  Based on the rotational crop metabolism it is 
considered that further rotational crop residues trials 
data are required to support the requested uses in soil 
grown crops that may be used in rotations in the 
greenhouse (not applicable for rotation of fruiting 
vegetables with fruiting vegetables). Residue 
definition for rotational crops is pending 
confirmation by these further data (currently 
proposed as: sum of Spiromesifen-4-hydroxymethyl 
(M02), spiromesifen-4-hydroxymethyl-glucoside 
(M03) and spiromesifen-4-hydroxymethyl 
conjugates).  
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Stability of residues (Annex IIA, point 6 introduction, Annex IIIA, point 8 introduction) 
……………………………………………..  Data for up to 2 years have been evaluated. Based on 
a residue definition of spiromesifen plus 
spiromesifen-enol (M01) expressed as spiromesifen, 
‘total residues’ (parent+ M01) are sufficiently stable 
over freezer storage for up to two years. There is 
evidence of conversion of parent to metabolite M01, 
and residues of parent alone are not stable over 
significant periods of freezer storage (varies 
according to crop but residues of parent were for 
example only stable for up to 6 months in French 
bean). 
 
 
Residues from livestock feeding studies (Annex IIA, point 6.4, Annex IIIA, point 8.3) 
Intakes by livestock  0.1 mg/kg diet/day:  Ruminant: 
no 
Poultry: 
no 
Pig: 
no 
Muscle       
Liver       
Kidney       
Fat       
Milk       
Eggs       
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Summary of critical residues data (Annex IIA, point 6.3, Annex IIIA, point 8.2) 
Crop Northern  or 
Mediterranean 
Region 
Trials results relevant to the critical GAP  
 
   (a) 
Recommendation/comments MRL STMR 
 
(b) 
Cucumber 
 
Glasshouse 
(N and S) 
0.03, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.14    0.2  0.06 
Tomato 
 
Glasshouse 
(N and S) 
0.09, 0.12, 0.16, 0.19, 0.19, 0.20, 0.22 
 
Cherry tomato:  
0.15, 0.10, 0.24, 0.17, 0.42, 0.11, 0.09, 0.50 
 1.0  0.17 
French bean 
 
Glasshouse 
(S only) 
0.04, 0.06, 0.07, 0.08, 0.09, 0.14, 0.26, 0.64    1.0  0.085 
Strawberry 
 
Glasshouse 
(N and S) 
0.08, 0.10, 0.12, 0.14, 0.19, 0.19, 0.29, 0.53    1.0  0.165 
Melon 
 
Glasshouse 
(S only) 
0.03, 0.04, 0.04, 0.04, 0.05. 0.06, 0.07, 0.07    0.1  0.045 
Pepper 
 
Glasshouse 
(N) 
0.06, 0.08, 0.11, 0.13, 0.18, 0.2, 0.2, 0.22    0.5   0.16 
 
(a) Numbers of trials in which particular residue levels were reported e.g. 3 x <0.01, 1 x 0.01, 6 x 0.02, 1 x 0.04, 1 x 0.08, 2 x 0.1, 2 x 0.15, 1 x 0.17 
(b) Supervised Trials Median Residue i.e. the median residue level estimated on the basis of supervised trials relating to the critical GAP 
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Consumer risk assessment (Annex IIA, point 6.9, Annex IIIA, point 8.8) 
ADI   0.03 mg/kg bw per day 
TMDI (European Diet) (% ADI)  WHO Cluster diet B = less than 14% 
NEDI (% ADI)  Total NEDI (UK model) = less than 4% 
Factors included in NEDI  STMR (and with regard to processing only a 2.1 x 
concentration processing factor for tomatoes (puree))
ARfD  2 mg/kg bw 
Acute exposure (% ARfD)  NESTI (UK model) = less than 1% 
IESTI = less than 3% 
 
 
Processing factors (Annex IIA, point 6.5, Annex IIIA, point 8.4) 
Crop/processed crop 
 
Number of studies Transfer 
factor
8 
% Transference *
9
Canned strawberry preserves  2  0.4  Parent 68% 
Strawberry jam  2  0.6  Parent 62% 
Washed and boiled beans  2  0.4  Parent 12% 
Peeled tomatoes  2  0.1  - 
Raw tomato juice  2  0.3  Parent 10% 
Tomato juice  2  0.3  Parent 5% 
Tomato puree  2  2.1  Parent 7% 
Wet tomato pomace  2  7.5  Parent 39% 
Canned tomato preserves  2  0.3  - 
* Calculated on the basis of distribution in the different portions, parts or products as determined through 
balance studies 
 
 
Proposed MRLs (Annex IIA, point 6.7, Annex IIIA, point 8.6) 
Proposed MRLs 
 
Note: Proposals were amended after the 
Meeting of experts and are not peer reviewed. 
Cucumber   0.2 mg/kg 
Courgette 0.2  mg/kg 
Tomato 1.0  mg/kg 
Aubergine 0.5  mg/kg 
(based on larger tomato data) 
French bean  1.0 mg/kg 
Strawberry 1.0  mg/kg 
Melon 0.1  mg/kg 
Pepper 0.5  mg/kg 
                                                      
8 calculated on the basis of the ‘total residue’ (spiromesifen and spiromesifen-enol expressed as spiromesifen equivalents) 
9 only calculated for spiromesifen residues as the RMS considered that spiromesifen-enol had been produced in part by 
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Appendix A.5: Fate and Behaviour in the Environment 
Route of degradation (aerobic) in soil (Annex IIA, point 7.1.1.1.1) 
Mineralization after 100 days ‡  Dihydrofuranone label:  50.5 – 71.0% AR (90 days), 
n=4 
Cyclopentyl label:  14.3% AR (90 days), n=1 
Phenyl label:  21.9% AR (90 days), n=1 
Non-extractable residues after 100 days ‡  Dihydrofuranone label:  16.2 – 22.9% AR (90 days), 
n=4 
Cyclopentyl label:  13.9% AR (90 days), n=1 
Phenyl label:  18.6% AR (90 days), n=1 
Relevant metabolites - name and/or code, % of 
applied ‡ (range and maximum) 
M01:  28.4 – 85.0% AR (7-14 days), n=6 
M09:  2.8 – 14.1% AR (14-90 days), n=6 
 
 
Route of degradation in soil - Supplemental studies (Annex IIA, point 7.1.1.1.2) 
Anaerobic degradation ‡ 
Mineralization after 100 days 
 
No study provided 
Non-extractable residues after 100 days 
 
No study provided 
Metabolites that may require further 
consideration for risk assessment - name 
and/or code, % of applied (range and 
maximum) 
No study provided 
Soil photolysis ‡ 
Metabolites that may require further 
consideration for risk assessment - name 
and/or code, % of applied (range and 
maximum) 
M01 11.6% AR at study end (10 DAT;  dark 
control 24.1% AR at study end, n= 1).  10 days 
study duration considered by study author to be 
equivalent to 34.3 solar days of natural sunlight at 
Phoenix, Arizona, USA in late June 1988. 
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Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
Laboratory studies ‡ 
Parent Aerobic  conditions 
Soil type  X
10 pH 
(CaC
l2) 
t. 
oC / % 
MWHC 
DT50 /DT90 
(d)  
DT50/DT90 
(d) 
20C 
pF2/10kPa 
St. 
(r
2) 
Method of 
calculation 
Silt   6.8  20
oC / 40%  3.5/11.6  3.3/11.0  >0.99  SFO 
Sandy loam    6.6  20
oC / 40%  2.9/9.6  2.3/7.7  >0.99  SFO 
Silty clay loam    6.2  20
oC / 75% 1/3 
bar 
11.7/38.8 10.6/35.3  >0.99  SFO 
Sandy loam    6.1  20
oC / 75% 1/3 
bar 
17.9/59.4 17.1/56.7  >0.99  SFO 
Sandy loam    8.2  20
oC / 75% 1/3 
bar 
3.8/12.7 1.9/6.3  >0.99  SFO 
Sandy loam    7.2  20
oC / 75% 1/3 
bar 
2.6/8.6 1.9/6.4  >0.99  SFO 
Geometric mean/median    5.2/17.4  4.1/13.8    SFO 
Above DT50 values temperature corrected to 10°C using Q10 of 2.58 
Soil type  X
11 pH 
(CaC
l2) 
t. 
oC / % 
MWHC 
DT50 /DT90 
(d)  
DT50/DT90 
(d) 
10C 
pF2/10kPa 
St. 
(r
2) 
Method of 
calculation 
Silt   6.8  20
oC / 40%  3.5/11.6  8.5/28.2  >0.99  SFO 
Sandy loam    6.6  20
oC / 40%  2.9/9.6  5.9/19.6  >0.99  SFO 
Silty clay loam    6.2  20
oC / 75% 1/3 
bar 
11.7/38.8 27.4/91.1  >0.99  SFO 
Sandy loam    6.1  20
oC / 75% 1/3 
bar 
17.9/59.4 44.2/146.8 >0.99  SFO 
Sandy loam    8.2  20
oC / 75% 1/3 
bar 
3.8/12.7 4.9/16.3  >0.99  SFO 
Sandy loam    7.2  20
oC / 75% 1/3 
bar 
2.6/8.6 4.9/6.5  >0.99  SFO 
              
 
Field studies ‡ 
Parent Aerobic  conditions 
                                                      
10 X This column is reserved for any other property that is considered to have a particular impact on the 
degradation rate. 
11 X This column is reserved for any other property that is considered to have a particular impact on the 
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Soil type 
(indicate if bare 
or cropped soil 
was used). 
Location 
(country or 
USA state). 
X
1  pH 
 
Depth 
(cm) 
DT50 (d) 
actual 
DT90(d
) 
actual 
St. 
(χ
2)
 
DT50 
(d) 
Norm. 
Method 
of 
calculatio
n  
No studies submitted, not triggered by parent DT50 lab 
 
pH dependence ‡ 
(yes / no) (if yes type of dependence) 
 No 
Soil accumulation and plateau concentration ‡  No studies submitted.  See PECsoil calculation 
 
Laboratory studies ‡ 
Parent Anaerobic  conditions 
Soil type  X
12 pH  t. 
oC / % 
MWHC 
DT50 / DT90 
(d)  
DT50 (d) 
20 C 
pF2/10kPa 
St. 
(r
2) 
Method of 
calculation 
No study submitted 
Geometric mean/median  n.a.         
Parent Soil  photolysis 
Sandy loam    7.2  20˚C, 75% of 
1/3 bar 
23.1/n.c.
a   >0.99  SFO 
a = DT50 extrapolated beyond study duration, DT90 not calculated;  dark control has same DT50 
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Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
Laboratory studies ‡ 
Metabolite M01    Aerobic conditions 
Soil type  X
13 pH 
(CaC
l2) 
t. 
oC / % 
MWHC 
DT50 /DT90 
(d)  
Formation 
fraction 
(from 
parent) 
DT50/DT90 
(d) 
20C 
pF2/10kPa 
St. 
(r
2) 
Method of 
calculation 
Silt   6.8  20
oC / 40%  8.8/29.4  1  8.4/28.0  >0.99  SFO 
Sandy loam    6.6  20
oC / 40%  13.3/43.4  1  10.6/34.7  >0.99  SFO 
Silty clay loam    6.2  20
oC / 75% 1/3 
bar 
12.6/42.1 1  11.5/38.4  0.99  SFO 
Sandy loam    6.1  20
oC / 75% 1/3 
bar 
13.6/45.4 1  13.0/43.4  >0.99  SFO 
Sandy loam    8.2  20
oC / 75% 1/3 
bar 
101.6/337.6 1 50.2/166.8  >0.99  SFO 
Sandy loam    7.2  20
oC / 75% 1/3 
bar 
53.7/178.4 1  39.8/132.4  >0.99  SFO 
Geometric mean/median    21.9/72.6  1  17.3/57.4    SFO 
 
  Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
  Laboratory studies ‡ 
Metabolite M09    Aerobic conditions 
Soil type  X
14 pH 
(CaC
l2) 
t. 
oC / % 
MWHC 
DT50 /DT90 
(d)  
Formation 
fraction 
(from M01) 
DT50/DT90 
(d) 
20C 
pF2/10kPa 
St. 
(r
2) 
Method of 
calculation 
Silt   6.8  20
oC / 40%  8.2/27.4  0.39  7.8/26.1  >0.99  SFO 
Sandy loam    6.6  20
oC / 40%  14.1/47.1  0.36  11.3/38.1  >0.99  SFO 
Silty clay loam    6.2  20
oC / 75% 1/3 
bar 
73.2/244.5 0.14  66.7/222.7  0.99  SFO 
Sandy loam    6.1  20
oC / 75% 1/3 
bar 
1.7/5.7 0.88  1.6/5.4  >0.99  SFO 
Sandy loam    8.2  20
oC / 75% 1/3 
bar 
223.6/742.8 0.39 110.5/366.9  >0.99  SFO 
Sandy loam    7.2  20
oC / 75% 1/3 
bar 
100.5/333.7 0.24 74.6/247.6  >0.99  SFO 
Geometric  mean/median   26.2/87.4  0.40* 20.6/69.1    SFO 
* Arithmetic mean 
                                                      
13 X This column is reserved for any other property that is considered to have a particular impact on the 
degradation rate. 
14 X This column is reserved for any other property that is considered to have a particular impact on the 
degradation rate. Peer review of the pesticide risk assessment of the active substance spiromesifen
 
EFSA Journal 2012;10(10):2879    36
 
Soil adsorption/desorption (Annex IIA, point 7.1.2) 
Kf /Koc ‡ 
 
Kd ‡ 
pH dependence ‡ (yes / no) (if yes type of 
dependence) 
Spiromesifen:  estimated Koc 30900 mL/g by the 
HPLC method 
M01 (Koc;1/n) 
8.3; 0.9313 
3.4; 0.7491 
3.7; 0.8843 
1.2; 0.7223 
M09 – tested on four soils, but Koc could only be 
determined on one soil (Koc = 3 mL/g) 
No pH dependence expected or determined for 
parent or metabolites 
 
Soil adsorption/desorption (Annex IIA, point 7.1.2) 
Spiromesifen  ‡ 
Soil Type  OC %  Soil pH  Kd 
(mL/g) 
Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
Data gap. Estimated Koc 30900 ml/g by HPLC method, this estimation was considered acceptable by 
the peer review only for the assessment of greenhouse uses.  pH dependence not expected. 
 
M01  ‡ 
Soil Type  OC %  Soil pH 
(H2O) 
Kd 
(mL/g) 
Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
Sandy loam  0.53  6.6      0.044  8.3  0.9313 
Silty clay loam  1.49  6.1      0.050  3.4  0.7491 
Sandy loam  1.80  7.0      0.067  3.7  0.8843 
Silt 2.62  7.8      0.031  1.2  0.7223 
Arithmetic mean   0.048  4.2  0.8218 
pH dependence (yes or no)  No 
 
M09 ‡ 
Soil Type  OC %  Soil pH  Kd 
(mL/g) 
Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
Tested on four soils, but Koc could only be determined on one soil (Koc = 3 mL/g).  pH dependence 
not determined.  However, with such little adsorption, impact of pH dependence is unlikely to make an 
impact on exposure calculations. 
 
 
Mobility in soil (Annex IIA, point 7.1.3, Annex IIIA, point 9.1.2) 
Column leaching ‡ 
 
Eluation (mm): 200 mm 
Time period (d): 2 d 
4 different soils, silty clay loam, sandy loam, sandy 
loam, silt. 
Leachate:  5.5 – 20.1% AR in leachate 
Active substance not detected in leachate, 4.6 – 
15.5% AR Met M01, 0.4 – 0.5% AR Met M09 
74.9 – 89.5% AR retained in soil, 63.0 – 81.5% AR 
retained in top 6cm 
Koc not calculated. Peer review of the pesticide risk assessment of the active substance spiromesifen
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Aged residues leaching ‡  Aged for (d):  6 d at 20°C and 75% of 1/3 bar 
Eluation (mm): 508 mm 
Time period (d): 5 d  
Single soil (sandy loam) 
Analysis of soil residues post ageing (soil residues 
pre-leaching): 60.5% AR spiromesifen, 34.8% AR 
Met M01, 0.9% AR unknowns. 
42.3% AR retained in soil column, 42.3% in top 
(treated) layer, 12.2% AR in top 6 cm.  
Spiromesifen 33.2% AR in soil, M01 4.0% AR in 
soil, 1.9% AR unknowns in soil. 
  Leachate: 53.2% AR in leachate 
0%AR active substance, 52.1% AR Met M01, 1% 
AR unknowns 
Koc not calculated. 
 
Lysimeter/ field leaching studies ‡ 
 
Not submitted. 
 
 
PEC (soil) (Annex IIIA, point 9.1.3) 
Parent 
Method of calculation  Crop interception of 50% 
Soil bulk density of 1.5 g/cm
3 
Equal distribution in the top 5cm soil layer 
Spiromesifen, 1st order DT50 of 17.9 days 
M01, 1st order DT50 of 101.6 days, 85.0% AR 
formation, molecular weight correction factor of 
0.725 
M09, 1st order DT50 of 223.6 days, 14.1% AR 
formation, molecular weight correction factor of 
0.819 
 
In order to calculate PECsoil values for the 
metabolites, it must be assumed that there is there is 
no degradation between applications.  This is due to 
uncertainties with respect to the formation profile of 
metabolites under multiple application regimes that 
are difficult to account for when using simple 
calculation approaches. 
Application rate  Four applications of 216 g a.s./ha per crop 
10 day interval between applications 
Spiromesifen 
PEC(s) 
(mg/kg) 
Single  
application 
Actual 
Single 
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial     0.353  0.353 Peer review of the pesticide risk assessment of the active substance spiromesifen
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Short term  24h 
                     2d 
                     4d 
   0.340 
0.327 
0.303 
0.346 
0.340 
0.327 
Long term    7d 
                   28d 
                   50d 
                 100d 
   0.269 
0.119 
0.051 
0.007 
0.309 
0.216 
0.156 
0.089 
 
M01 
PEC(s) 
(mg/kg) 
Single  
application 
Actual 
Single 
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial     0.355  0.355 
Short term  24h 
                     2d 
                     4d 
   0.353 
0.350 
0.345 
0.354 
0.353 
0.350 
Long term    7d 
                   28d 
                   50d 
                 100d 
   0.338 
0.293 
0.252 
0.179 
0.347 
0.323 
0.301 
0.257 
 
M09 
PEC(s) 
(mg/kg) 
Single  
application 
Actual 
Single 
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial     0.066  0.066 
Short term  24h 
                     2d 
                     4d 
   0.066 
0.066 
0.066 
0.066 
0.066 
0.066 
Long term    7d 
                   28d 
                   50d 
                 100d 
   0.065 
0.061 
0.057 
0.049 
0.066 
0.064 
0.062 
0.057 
 
Accumulation potential of M09 addressed as follows: 
two crops per year in a glasshouse, 
each crop treated with 216 g a.s./ha x4, 
10 day spray interval in each crop, 
intervals between the finish and start of spray programmes of 76 days and 229 days (as proposed in the 
applicants groundwater modelling), 
50% interception, 
1st order DT50 of 223.6 days, 14.1% AR formation, molecular weight correction factor of 0.819 
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Due to uncertainties in respect to the profile of formation and decline of M01 under multiple application 
regimes, it is assumed that there is no degradation of the parent between each set of four applications. Thus for 
the purposes of calculation, it is assumed that there are two applications of 864 g a.s./ha with intervals of 106 and 
259 days between the applications every year. 
 
Using this method, the peak concentration of M09 would be predicted to plateau at 0.169 mg/kg at the end of the 
6th year of applications. 
 
Route and rate of degradation in water (Annex IIA, point 7.2.1) 
Hydrolytic degradation of the active substance 
and metabolites > 10 % ‡ 
pH 4 at 20°C:  107.3 days 
Major metabolite M01, max. formation @ 25°C, 
pH 4, 30 DAT, 27.5% AR.  No other major 
metabolites. 
  pH 7 at 20°C:  44.7 days 
Major metabolite M01, max. formation @ 25°C, 
pH 7, 30 DAT, 54.3% AR.  No other major 
metabolites. 
  pH 9 at 20°C:  4.8 days 
Major metabolite M01, max. formation @ 25°C, 
pH 9, 30 DAT, 95.7% AR.  No other major 
metabolites. 
Photolytic degradation of active substance and 
metabolites above 10 % ‡ 
 
Spiromesifen DT50 1.7 days (equivalent 5.8 days 
Arizona, USA mid summer) 
Major metabolites at 5 DAT:  M01, 12.3 %AR;  
M16, 35.8% AR;  M17, 36.6% AR 
M01 stable with respect to photolysis 
Readily biodegradable (yes/no)  No study submitted therefore substance considered 
not readily biodegradable. 
 
Degradation in water / sediment 
Parent  Distribution (max in water 20.7 – 44.1% AR at 0 d. Max. sed 62.3 – 83.6% AR after 
1 - 2 d) 
Water / 
sediment 
system 
pH 
water 
phase  
pH 
sed 
t. 
oC   DT50-DT90 
whole sys. 
St. 
(r
2
) 
DisT50-
DisT90 
water 
St. 
(r
2
) 
DisT50- 
DisT90 
Sed (from 
max) 
St. 
(r
2
)
 
Method of 
calculation
‘Fresno’ 8.3  7.0  20  4.1/13.6  d 
(SFO) 
0.9
87 
0.1/2 (√1
st)0 . 9
6 
6/20 
(SFO) 
0.9
3 
 
‘German 
sediment’ 
8.4 5.5  20  7.8/26.0  d 
(SFO) 
0.9
82 
0.2/2 (√1
st)0 . 9
8 
10/33 
(SFO) 
0.9
3 
 
Geometric mean/median              
 
Metabolite 
M01 
Distribution (max in water 71.7 – 84.1% AR at 45 – 105 DAT. Max. sed 15.7 - 38% 
AR after 9 – 90 d) 
Water / 
sediment 
system 
pH 
water 
phase 
pH 
sed 
t. 
oC   DT50-DT90 
whole sys. 
St. 
(r
2
) 
DisT50-
DisT90 
Water 
(from 
peak) 
r
2 DT50- 
DT90 
sed 
St. 
(r
2
)
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‘Fresno’ 8.3  7.0  20  Not  calc    240/797  d 
(SFO)* 
0.6
4 
Not calc     
‘German 
sediment’ 
8.4  5.5  20  Not calc    42/139 d 
(SFO)* 
0.9
6 
Not calc     
Geometric mean/median              
*  Only 4 sample points (duplicate samples) available 
 
Mineralization and non extractable residues 
Water / 
sediment 
system 
pH 
water 
phase 
pH 
sed 
Mineralization  
x % after n d. (end 
of the study). 
Non-extractable 
residues in sed. Max 
x % after n d 
Non-extractable residues 
in sed. Max x % after n d 
(end of the study) 
‘Fresno’  8.3  7.0  2.1% AR at 63 d  3.0% AR at 120 d 
(study end) 
3.0% AR at 120 d (study 
end) 
‘German 
sediment’ 
8.4  5.5  1.4% AR at 90 d 
(study end) 
16.7% AR at 76 d  16.4% AR at 90 d (study 
end) 
 
 
PEC (surface water) (Annex IIIA, point 9.2.3) 
Spiromesifen 
Method of calculation  Water depth 30cm 
Sediment depth 5cm with bulk density 1.3 g/cm
3 
Spiromesifen, sq. rt. 1st order DT50 of 0.2 days from 
water phase. 
Application rate  Four applications of 216 g a.s./ha per crop 
10 day interval between applications 
Main routes of entry  0.1% emission into surface water (Dutch scenario, 
example purposes in absence of agreed European 
method for calculation of PEC(sw) from glasshouse 
use) 
 
PEC(sw) 
(μg / l) 
Single  
application 
Actual 
 
Single  
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial  0.072     
Short term   4h 
                     2d 
                     4d 
0.015 
0.008 
0.003 
   
Long term    7d 
                   14d 
                   21d 
                   28d 
                   42d 
0.001 
0.000 
0.000 
0.000 
0.000 
   
 
Due to rapid dissipation in surface water, there are no differences between single or multiple applications. 
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Pseudo-PECsw for spiromesifen for use in the sediment dwelling organisms risk assessment was calculated 
assuming 0.1% emission of the maximum total dose of 864 g a.s./ha per crop. This results in a concentration of 
0.288 µg/L. This would increase to 0.384 µg/L for 6 applications per year if the product is use in a second crop 
within the same calendar year with only two applications (assumes four applications of 216 g a.s./ha + 2x 144 g 
a.s./ha)  
The maximum formation of metabolite M01 was 89.7% AR; a molecular weight correction factor of 0.725 from 
the parent is appropriate. Given that peak concentrations were formed with only four sample times remaining in 
the study, reliable dissipation rates for the water phase cannot be calculated. However, data from Fresno system 
would suggest that dissipation of M01 may be relatively slow. Thus a maximum PECsw has been calculated on 
the assumptions given above. Given the relative apparent persistence of this metabolite, no degradation between 
applications is assumed. The peak concentration following four applications would be 0.187 µg/L. This would 
increase to 0.250 µg/L for six applications per year. 
 
 
PEC (sediment) 
Method of calculation  Water depth 30cm 
Sediment depth 5cm with bulk density 1.3 g/cm
3 
Spiromesifen, 1st order DT50 10 days following final 
application (note no degradation assumed between 
applications) 
0.1% emission into surface water (Dutch scenario, 
example purposes in absence of agreed European 
method for calculation of PECsw from glasshouse 
use) 
Application rate  Four applications of 216 g a.s./ha per crop 
10 day interval between applications 
Main routes of entry  Undefined emission route 
 
PEC(sed 
(μg / l) 
Single  
application 
Actual 
 
Single  
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial    1.111  1.111 
Short term  2d      0.967  1.038 
Long term  28d      0.160  0.490 
 
No increased sediment concentrations would be expected following six applications per year. 
 
Metabolite M01 occurred in sediment at a maximum of 38.0% AR at study termination. Thus a maximum 
PECsed has been calculated using standard water body assumptions above, no degradation between applications 
and a molecular weight correction factor of 0.725. The maximum PECsed would be 0.366 µg/kg. This would 
increase to 0.488 µg/kg for 6 applications as notified. 
 
 
PEC (ground water) (Annex IIIA, point 9.2.1) 
Method of calculation and type of study (e.g.  
modelling, monitoring, lysimeter ) 
FOCUS PELMO modelling modified to consider use under 
glasshouse conditions. 
Scenario parameters modified from FOCUS defaults: 
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Crop related parameters 
 
Temperature related statistics 
NE temperatures based on Hamburg scenario but modified 
according to:  
SE temperatures based on measured data in Spanish 
greenhouse situations 
Daily irrigation (l/m2/day) 
 
Application rate  N. Europe – 4 x 0.216 kg a.s./ha/year 
S. Europe - 4 x 0.216 + 4 x 0.144 kg a.s./ha/year 
Application regime 
PEC(gw) 
Maximum concentration  Not calculated by FOCUS model shells, not required. 
Average annual concentration  Data gap Peer review of the pesticide risk assessment of the active substance spiromesifen
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(Results quoted for modelling with FOCUS gw 
scenarios, according to FOCUS guidance) 
concentration (80
th percentile) 
 
Available calculations were performed assuming a Q10 = 
2.2. The use of a Q10 = 2.58 has been required during the 
Regulation (EU) 188/2011 procedure.  
 
 
Fate and behaviour in air (Annex IIA, point 7.2.2, Annex III, point 9.3) 
Direct photolysis in air ‡  Not available, not required. 
Quantum yield of direct phototransformation    = 0.00101 (from photolysis in water) 
Photochemical oxidative degradation in air ‡  DT50 of 1.69 hours derived by the Atkinson model 
(AOPWIN version 1.87). OH (12 h) concentration 
assumed = 1.5 x 10
6 OH radicals/cm
3 
Volatilization ‡  from plant surfaces: Not available, not required. 
  from soil: Not available, not required. 
 
 
PEC (air) 
Method of calculation  Not done, no guidance available 
 
PEC(a) 
Maximum concentration  Assumed to be negligible. 
 
 
Definition of the Residue for risk assessment (Annex IIA, point 7.3) 
Relevant to the environment  Soil: spiromesifen, M01 and M09 
Surface water: spiromesifen, M01, M16
*) and M17
*) 
Sediment: spiromesifen and M01 
Groundwater: spiromesifen, M01 and M09  
Air: spiromesifen 
 
*) the photolysis metabolites M16 and M17 are 
major metabolites in the photolysis study. However, 
they do not need to be assessed in ecotoxicology as 
sorption to sediment will be the main route of 
dissipation and these metabolites are not expected to 
be formed in significant amounts under natural 
conditions. 
Monitoring data, if available (Annex IIA, point 7.4) 
Soil (indicate location and type of study)  Not available 
Surface water (indicate location and type of 
study) 
Not available 
Ground water (indicate location and type of 
study) 
Not available 
Air (indicate location and type of study)  Not available Peer review of the pesticide risk assessment of the active substance spiromesifen
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Classification and proposed labelling (Annex IIA, point 10) 
with regard to fate and behaviour data   Candidate for  
R53  May cause long-term adverse effect in the 
aquatic environment 
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Appendix A.6: Effects on non-target Species 
Effects on terrestrial vertebrates (Annex IIA, point 8.1, Annex IIIA, points 10.1 and 10.3) 
Acute toxicity to mammals ‡(Rattus rattus) LD50 > 2500 mg a.s./kg bw  
(from study with ‘BSN 2060 240 SC’) 
Acute toxicity to birds ‡(Colinus virginianus) LD50 > 2000 mg a.s./kg bw 
Dietary toxicity to birds ‡(Colinus virginianus 
and Anas platyrhynchos) 
LC50 >5000 ppm a.s. 
Reproductive toxicity to birds (Anas 
platyrhynchos 
NOEC 229 ppm a.s. 
NOED 23.2 mg a.s./kg bw/d 
Reproductive toxicity to mammals  NOEC 30 ppm a.s. 
NOED 3.3 mg a.s./kg bw/d (2 generation rat study) 
 
 
Toxicity/exposure ratios for terrestrial vertebrates (Annex IIIA, points 10.1 and 10.3) 
Application 
rate 
(kg as/ha) 
Crop Category 
(e.g. insectivorous 
bird) 
Time-scale TER  Annex  VI 
Trigger 
0.216 Various  crops 
under protection 
Fish-eating mammal  Long-term  268  5 
0.216 Various  crops 
under protection 
Fish-eating bird  Long-term  2830  5 
 
Toxicity data for aquatic species (most sensitive species of each group) (Annex IIA, point 8.2, 
Annex IIIA, point 10.2) 
Group Test  substance  Time-scale  Endpoint  Toxicity 
(mg/L) 
Laboratory tests ‡ 
Fish (Oncorhynchus 
mykiss) 
spiromesifen 96h  LC50 0.016  a.s. 
Fish (Lepomis 
macrochirus) 
spiromesifen 96h  LC50  > 0.034 a.s. 
Free swimming 
invertebrate (Daphnia 
magna) 
spiromesifen 48h  EC50  > 0.092 a.s. 
Alga 
(Pseudokirchneriella 
subcapitata) 
spiromesifen 96  h  ErC50 
EbC50 
> 0.094 a.s. 
> 0.094 a.s. 
Fish (Oncorhynchus 
mykiss) 
M01 96h  LC50  > 100 M01 
Fish (Oncorhynchus 
mykiss) 
M09 96h  LC50  > 87.4 M09 Peer review of the pesticide risk assessment of the active substance spiromesifen
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Group Test  substance  Time-scale  Endpoint  Toxicity 
(mg/L) 
Free swimming 
invertebrate (Daphnia 
magna) 
M01 48h  EC50  > 100 M01 
Free swimming 
invertebrate (Daphnia 
magna) 
M09 48h  EC50  > 100 M09 
Alga 
(Pseudokirchneriella 
subcapitata) 
M01 72h  ErC50 
EbC50 
50.2 M01 
17.9 M01 
Alga 
(Pseudokirchneriella 
subcapitata)  
M09 72h  ErC50 
EbC50 
64 M09 
71 M09 
Fish (Oncorhynchus 
mykiss) 
‘BSN 2060 240 
SC’ 
96h  LC50  0.105 a.s. 
Fish (Lepomis 
macrochirus) 
‘BSN 2060 240 
SC’ 
96h  LC50  0.057 a.s. 
Free swimming 
invertebrate (Daphnia 
magna) 
‘BSN 2060 240 
SC’ 
48h EC50 15.9  a.s. 
Alga 
(Pseudokirchneriella 
subcapitata) 
‘BSN 2060 240 
SC’ 
72h ErC50 
EbC50 
>1.48 a.s. 
>1.48 a.s. 
Fish (Oncorhynchus 
mykiss) 
spiromesifen 97d  NOEC  0.00473  a.s.
Free swimming 
invertebrate (Daphnia 
magna) 
spiromesifen  21 d  NOEC  0.00025 a.s.
Sediment dwelling 
invertebrate 
(Chironomus riparius) 
spiromesifen  28 d  NOEC  0.032 a.s. 
Fish (Oncorhynchus 
mykiss) 
M01  88 d  NOEC  > 9.2 M01 
Free swimming 
invertebrate (Daphnia 
magna) 
M01  21 d  NOEC  0.186 M01 
 
Microcosm or mesocosm tests 
A NOEC could not be defined (see report of Pesticides Peer Review Meeting 91 (23 – 27 April 2012)).
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Toxicity/exposure ratios for the most sensitive aquatic organisms (Annex IIIA, point 10.2) 
Application 
rate 
(kg as/ha) 
Crop Organism  Time-scale  TER  Annex  VI
Trigger 
Spiromesifen 
0.216  Various crops under 
protection 
Fish (Oncorhynchus 
mykiss) 
96 h  222  100 
0.216  Various crops under 
protection 
Free swimming 
invertebrate (Daphnia 
magna) 
48 h  > 1278  100 
0.216  Various crops under 
protection 
Alga 
(Pseudokirchneriella 
subcapitata) 
96 h  > 1306  10 
0.216  Various crops under 
protection 
Fish (Oncorhynchus 
mykiss) 
97 d  65.7  10 
0.216  Various crops under 
protection 
Free swimming 
invertebrate (Daphnia 
magna) 
21 d  3.5   10 
0.216  Various crops under 
protection 
Sediment dwelling 
invertebrate 
(Chironomus riparius)
28 d  83  10 
M01 / M09* 
0.216  Various crops under 
protection 
Fish (Oncorhynchus 
mykiss) 
96 h  > 400000  100 
0.216  Various crops under 
protection 
Free swimming 
invertebrate (Daphnia 
magna) 
96 h  > 400000  100 
0.216  Various crops under 
protection 
Algae (Pseudokirch-
neriella subcapitata) 
72 h  71600  10 
0.216  Various crops under 
protection 
Fish (Oncorhynchus 
mykiss) 
88 d  > 36800  10 
0.216  Various crops under 
protection 
Free swimming 
invertebrate (Daphnia 
magna) 
21 d  744  10 
* TERs for M09 were not reported, however, considering the similar toxicity of M01 and M09, the 
risk assessment for M01 covers the risk assessment for M09. 
 
Bioconcentration 
Bioconcentration factor (BCF) ‡  545 
Annex VI Trigger:for the bioconcentration factor 100 
Clearance time     (CT50) 
                              (CT90) 
0.7 d 
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Level of residues (%) in organisms after the 14 
day depuration phase 
1% of that at day 28 of exposure to 0.1 g/L 
1.8% of that of day 28 of exposure to 1.0 g/L 
 
 
Effects on honeybees (Annex IIA, point 8.3.1, Annex IIIA, point 10.4) 
Acute oral toxicity ‡  LD50 792.4 g a.s./bee (a.s. test) 
LD50 > 60.2 g a.s./bee (product test) 
Acute contact toxicity ‡  LD50 > 200 g a.s./bee (a.s.test) 
LD50 > 200 g a.s./bee (product test) 
 
Field or semi-field tests 
30 day study with Bombus terrestris. Fed sugar syrup containing 144 mg a.s./L and pollen sprayed 4 x 
with solution containing 0.06% BSN 2060 SC 240 ((240 g spiromesifen/L). 0.72 mg a.s./bee/week 
consumed as sugar syrup. Intake as pollen not defined. 
No effects on adult survival or behaviour. Statistically significant reduction in number of drones 
produced. 
 
 
Hazard quotients for honey bees (Annex IIIA, point 10.4) 
Not relevant as use only in permanent greenhouse. 
 
 
Effects on other arthropod species (Annex IIA, point 8.3.2, Annex IIIA, point 10.5) 
Species Stage  Test 
Substance 
Dose 
(kg as/ha) 
Endpoint Effect  Annex  VI 
Trigger 
Laboratory tests ‡ 
Aphidius 
rhopalosiphi 
 
(Laboratory) 
Adult BSN  2060 
SC240 
9 mL/ha 
 
18 mL/ha 
 
45 mL/ha 
 
110 mL/ha 
 
270 mL/ha 
M 
F 
M 
F 
M 
F 
M  
 
LR50 
7.5% 
59.22% 
10% 
45.43% 
57.5% 
NA 
97.5% 
NA 
100% 
NA 
 
40.63 mL/ha 
(95% CL 
31.18-48.87) 
30% 
effects 
 
Aphidius 
rhopalosiphi 
 
(Extended 
laboratory) 
Adult BSN  2060 
SC240 
600 g a.s./ha 
 
864 g a.s./ha 
M 
F 
M 
F 
2.7% 
79% 
-2.7% 
91.33% 
30% 
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Species Stage  Test 
Substance 
Dose 
(kg as/ha) 
Endpoint Effect  Annex  VI 
Trigger 
Typhlodromus 
pyri 
 
Adult BSN  2060 
SC240 
12 g a.s./ha 
 
24 g a.s./ha 
 
50.4 g a.s./ha 
 
105.6 g a.s./ha 
 
216 g a.s./ha 
 
 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
17% 
18% 
7% 
5% 
54% 
28% 
64% 
NA 
76% 
NA 
 
LR50 68.4 g 
a.s/ha (95%CL 
38.9-108) 
30% 
Chrysoperla 
carnea 
 
 
Larvae BSN  2060 
SC240 
0.9 L prod/ha 
 
 
1.8 L prod/ha 
 
 
3.6 L prod/ha 
M 
F 
H 
M 
F 
H 
M 
F 
H 
-0.02% 
105% 
102% 
-0.02% 
108% 
100% 
6.9% 
105% 
100% 
30% 
Coccinella 
septempunctata 
 
 
Larvae BSN  2060 
SC240 
45 mL prod/ha 
 
95 mL prod/ha 
 
200 mL prod/ha 
 
425 mL prod/ha 
 
900 mL prod/ha 
M 
F 
M 
F 
M 
 
M 
 
M 
 
12.9% 
98% 
33.1% 
54% 
50.8% 
 
81.1% 
 
92.4% 
 
LR50 169 mL 
prod/ha 
30% 
Poecilus cupreus Adult   0.9  L  prod/ha 
 
1.8 L prod/ha 
 
2.7 L prod/ha 
M 0% 
C 93% 
M 0% 
C 117% 
M 0% 
C 114% 
30%  
Aleochara 
bilineata 
Larvae    224.2 g a.s./ha 
4x at 7 day 
intervals 
Emergence 92%  Peer review of the pesticide risk assessment of the active substance spiromesifen
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Species Stage  Test 
Substance 
Dose 
(kg as/ha) 
Endpoint Effect  Annex  VI 
Trigger 
Field or semi-field tests 
NA 
M = % mortality (corrected for control mortality) 
F = fecundity as % of control fecundity 
H = hatching rate as % of control hatching rate 
C = food consumption 
 
 
Effects on earthworms (Annex IIA, point 8.4, Annex IIIA, point 10.6) 
Acute toxicity ‡  LC50 > 1000 mg a.s./kg soil (a.s. and product tests) 
LC50 > 1000 mg M01/kg soil 
LC50 > 1000 mg M09/kg soil 
Reproductive toxicity ‡  Based on study with active substance 
 LC50 > 4.32 mg a.s./kg 
NOEC 4.32 mg a.s./kg 
  Based on study with formulated product, ‘BSN 2060 
SC 240’ 
 LC50 >1 mg a.s./kg 
NOEC 1 mg a.s./kg soil 
 
Endpoints adjusted ( x 0.5) for organic matter content of test soil. 
Acute toxicity  LC50 > 500 mg a.s./kg soil (a.s. and product tests) 
Reproductive toxicity  Based on study with active substance 
 LC50 > 2.16 mg a.s./kg 
NOEC 2.16 mg a.s./kg 
  Based on study with formulated product, ‘BSN 2060 
SC 240’ 
 LC50 > 0.50 mg a.s./kg  
NOEC 0.50 mg a.s./kg soil 
 
Toxicity/exposure ratios for earthworms (Annex IIIA, point 10.6) 
Not relevant as use only in permanent greenhouse. 
 
 
Effects on soil micro-organisms (Annex IIA, point 8.5, Annex IIIA, point 10.7) 
Nitrogen mineralization ‡  No effect at 2.96 mg a.s./kg soil (=2.16 kg a.s./ha) 
No effect at 11.9 l ‘BSN 2060 SC240’/kg soil  
(-9 L/ha) 
No effect at 1.07 mg M01/kg soil (= 0.8 kg/ha) 
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Carbon mineralization ‡  No effect at 2.96 mg/kg soil (=2.16 kg a.s./ha) 
No effect at 11.9 l ‘BSN 2060 SC240’/kg soil  
(-9 L/ha) 
 
Effects on non-target plants (Annex IIA, point 8.6, Annex IIIA, point 10.8) 
Not relevant as only use in permanent greenhouse. 
 
 
Effects on biological methods for sewage treatment (Annex IIA 8.7)  
Test type/organism  end point 
Activated sludge  >1000 mg a.s./L 
 
 
Classification and proposed labelling (Annex IIA, point 10)* 
with regard to ecotoxicological data  Dangerous for the environment 
 
R50  Very toxic to aquatic organisms 
R53  May cause long term adverse effects in the 
aquatic environment 
 
S60  This material and its container must be 
disposed of as hazardous waste 
S61  Avoid release to the environment. Refer to 
special instructions/Safety Data 
 
* It should be noted that classification is formally proposed and decided in accordance with 
Regulation (EC) No 1272/2008.  Proposals for classification made in the context of the evaluation 
procedure under Regulation (EC) No 1107/2009 are not formal proposals. 
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APPENDIX B – USED COMPOUND CODE(S) 
Code/Trivial name*  Chemical name**  Structural formula** 
N,N-dimethylacetamide  N,N-dimethylacetamide 
O
N
 
M01  
(BSN 2060-enol, BSN 0546)  
4-hydroxy-3-mesityl-1-
oxaspiro[4.4]non-3-en-2-one  O
C H3
CH3
CH3
OH
O
 
M02 
(4-hydroxymethyl-BSN 0546) 
4-hydroxy-3-[4-(hydroxymethyl)-
2,6-dimethylphenyl]-1-
oxaspiro[4.4]non-3-en-2-one 
O CH3
CH3
OH
O
O H
 
M03 
(4-hydroxymethyl-glucoside-
BSN 0546) 
4-hydroxy-3-[4-(hydroxymethyl)-
2,6-dimethylphenyl]-1-
oxaspiro[4.4]non-3-en-2-one 
glucoside 
O CH3
CH3
OH
O
O
Glucose  
M04 
(dihydroxy-BSN 0546) 
 
dihydroxy spiromesifen enol (the 
exact position of the OH groups 
could not be determined) 
4,x,y-trihydroxy-3-mesityl-1-
oxaspiro[4.4]non-3-en-2-one 
O
CH3
CH3
C H3
O H
O
O H
OH
 
M09 
(4-carboxy-BSN 0546) 
4-(4-hydroxy-2-oxo-1-
oxaspiro[4.4]non-3-en-3-yl)-3,5-
dimethylbenzoic acid 
O
HOOC
CH3
CH3
OH
O
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M16 
(BSN 2060-cyclobutyl 
photoisomer) 
3,5-dimethyl-5'-
oxodispiro[bicyclo[4.2.0]octa-
1,3,5-triene-7,4'-furan-2',1''-
cyclopentan]-3'-yl 3,3-
dimethylbutanoate 
 
O
C H3
CH3
O
O
H O
CH3
CH3
C H3  
M17 
(BSN 0546 photoisomer) 
 
8'-hydroxy-4',6'-dimethyl-8',8a'-
dihydrospiro[cyclopentane-1,1'-
indeno[1,2-c]furan]-3'(3a'H)-one 
O
C H3
CH3
OH
O  
* The metabolite name in bold is the name used in the conclusion. 
**ACD/ChemSketch, Advanced Chemistry Development, Inc., ACD/Labs Release: 12.00 Product version:   
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ABBREVIATIONS 
1/n  slope of Freundlich isotherm 
λ wavelength 
  decadic molar extinction coefficient 
°C  degree Celsius (centigrade) 
µg microgram 
µm micrometer  (micron) 
a.s. active  substance 
AChE acetylcholinesterase 
ADE  actual dermal exposure 
ADI  acceptable daily intake 
AF assessment  factor 
AOEL  acceptable operator exposure level 
AP alkaline  phosphatase 
AR applied  radioactivity 
ARfD  acute reference dose 
AST  aspartate aminotransferase (SGOT) 
AV avoidance  factor 
BCF bioconcentration  factor 
BUN  blood urea nitrogen 
bw body  weight 
CAS  Chemical Abstracts Service 
CFU  colony forming units 
ChE cholinesterase 
CI confidence  interval 
CIPAC  Collaborative International Pesticides Analytical Council Limited 
CL confidence  limits 
cm centimetre 
d day 
DAA  days after application 
DAD  diode array detector 
DAR  draft assessment report 
DAT  days after treatment 
DM dry  matter 
DT50  period required for 50 percent disappearance (define method of estimation) 
DT90  period required for 90 percent disappearance (define method of estimation) 
dw dry  weight 
EbC50  effective concentration (biomass) 
EC50 effective  concentration 
ECHA  European Chemical Agency 
EEC  European Economic Community 
EINECS  European Inventory of Existing Commercial Chemical Substances 
ELINCS  European List of New Chemical Substances 
EMDI  estimated maximum daily intake 
ER50  emergence rate/effective rate, median 
ErC50  effective concentration (growth rate) 
EU European  Union 
EUROPOEM  European Predictive Operator Exposure Model 
f(twa)  time weighted average factor 
FAO  Food and Agriculture Organisation of the United Nations 
FID  flame ionisation detector 
FIR  Food intake rate 
FOB  functional observation battery 
FOCUS  Forum for the Co-ordination of Pesticide Fate Models and their Use Peer review of the pesticide risk assessment of the active substance spiromesifen
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g gram 
GAP  good agricultural practice 
GC gas  chromatography 
GCPF  Global Crop Protection Federation (formerly known as GIFAP) 
GGT  gamma glutamyl transferase 
GM geometric  mean 
GS growth  stage 
GSH glutathion 
h hour(s) 
ha hectare 
Hb haemoglobin 
Hct haematocrit 
hL hectolitre 
HPLC  high pressure liquid chromatography  
or high performance liquid chromatography 
HPLC-MS  high pressure liquid chromatography – mass spectrometry 
HQ hazard  quotient 
IEDI  international estimated daily intake 
IESTI  international estimated short-term intake 
ISO  International Organisation for Standardisation 
IUPAC International  Union  of  Pure and Applied Chemistry 
JMPR  Joint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and 
the Environment and the WHO Expert Group on Pesticide Residues (Joint 
Meeting on Pesticide Residues) 
Kdoc  organic carbon linear adsorption coefficient 
kg kilogram 
KFoc  Freundlich organic carbon adsorption coefficient 
L litre 
LC liquid  chromatography 
LC50  lethal concentration, median 
LC-MS  liquid chromatography-mass spectrometry 
LC-MS-MS  liquid chromatography with tandem mass spectrometry 
LD50  lethal dose, median; dosis letalis media 
LDH lactate  dehydrogenase 
LOAEL  lowest observable adverse effect level 
LOD  limit of detection 
LOQ  limit of quantification (determination) 
m metre 
M/L  mixing and loading 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
mg milligram 
mL millilitre 
mm millimetre 
mN milli-newton 
MRL  maximum residue limit or level 
MS mass  spectrometry 
MSDS  material safety data sheet 
MTD  maximum tolerated dose 
MWHC  maximum water holding capacity 
NESTI national  estimated short-term intake 
ng nanogram 
NOAEC  no observed adverse effect concentration 
NOAEL  no observed adverse effect level Peer review of the pesticide risk assessment of the active substance spiromesifen
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NOEAEC  no observed ecologically adverse effect concentration 
NOEC  no observed effect concentration 
NOEL  no observed effect level 
OECD  Organisation for Economic Co-operation and Development  
OM  organic matter content 
Pa pascal 
PD  proportion of different food types 
PEC  predicted environmental concentration 
PECair  predicted environmental concentration in air 
PECgw  predicted environmental concentration in ground water 
PECsed  predicted environmental concentration in sediment 
PECsoil  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
pH pH-value 
PHED  pesticide handler's exposure data 
PHI pre-harvest  interval 
pKa  negative logarithm (to the base 10) of the dissociation constant 
Pow  partition coefficient between n-octanol and water 
PPE  personal protective equipment 
ppm  parts per million (10
-6) 
ppp  plant protection product 
PT  proportion of diet obtained in the treated area 
PTT  partial thromboplastin time 
QSAR  quantitative structure-activity relationship 
r
2  coefficient of determination 
REACH  Registration, Evaluation, Authorisation of CHemicals  
RPE  respiratory protective equipment 
RUD  residue per unit dose 
SC suspension  concentrate 
SFO single  first-order 
SSD species  sensitivity  distribution 
STMR  supervised trials median residue 
t1/2  half-life (define method of estimation) 
TER  toxicity exposure ratio 
TERA  toxicity exposure ratio for acute exposure 
TERLT  toxicity exposure ratio following chronic exposure 
TERST  toxicity exposure ratio following repeated exposure 
TK technical  concentrate 
TLV  threshold limit value 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
TSH  thyroid stimulating hormone (thyrotropin) 
TWA  time weighted average 
UDS unscheduled  DNA  synthesis 
UV ultraviolet 
W/S water/sediment 
w/v  weight per volume 
w/w  weight per weight 
WBC  white blood cell 
WG  water dispersible granule 
WHO  World Health Organisation 
wk week 
yr year 
 